Perinatal Exposure to Low Doses of Dioxin Can Permanently Impair Human Semen Quality by Mocarelli, Paolo et al.
Environmental Health Perspectives  •  v o l u m e  119 | n u m b e r 5 | May 2011  713
Research | Children’s Health
For the past 50 years, scientists have debated 
the issue of a reported decline in human 
semen quality, especially in Western countries 
(Carlsen et al. 1992; Swan et al. 2000). There 
is now a general consensus that human sperm 
quality has declined over time in different areas 
of the world (Auger et al. 1995; Jørgensen et al. 
2001; Swan et al. 2003), especially in younger 
men (López-Teijòn et al. 2008; Zheng et al. 
1997), with indications of concurrent male 
sub- or infertility (Bonde et al. 1998; Paasch 
et al. 2008; Zheng et al. 1997).
No clear causes have been identified; 
however, selected widespread persistent envi-
ronmental endocrine-disrupting chemicals, 
such as 2,3,7,8-tetrachlorodibenzo-p-dioxin 
(TCDD) and other dioxin-like chemicals, are 
suspected to be potential etiologic agents, as 
demonstrated in experimental animals, but 
no definitive data are available for men.
Recently, we showed that exposure 
in infancy to low doses of dioxin induces a 
sperm concentration reduction of about 25%; 
however, no reduction is observed if similar 
exposures occur during adulthood (Mocarelli 
et al. 2008). These data are consistent with 
animal models, which have demonstrated that 
the most sensitive times for these effects were 
exposures while in utero and during breast-
feeding (Faqui et al. 1998).
In infants, after 4–5 months of breast-
feeding, dioxin serum concentrations increase 
up to 2-fold (Abraham et al. 1998). In that 
period, there is a hormonal surge (Forest et al. 
1973; Quigley 2002), defined as “neonatal 
minipuberty,” in which an increase of follicle-
stimulating hormone (FSH) and inhibin B 
(Andersson et al. 1998) induces and reflects 
a strong proliferation of Sertoli cells (Cortes 
et al. 1987), the number of which determines 
how many germ cells can develop into sper-
matozoa (Sharpe et al. 2003). In addition 
to exposure during in utero development, 
exposure to TCDD within this developmen-
tal window could induce a direct or indirect 
toxic effect (i.e., imbalance of the hormonal 
equilibrium), impairing such proliferation 
and reducing sperm production in adults.
In this study, we assessed the association 
between human dioxin exposure in utero and 
during breast-feeding and adverse human adult 
male reproductive outcomes, as measured in 
men whose mothers were exposed to dioxin 
as a result of the trichlorophenol plant explo-
sion near Seveso, Italy, in July 1976 (Mocarelli 
et al. 1991; Needham et al. 1997–1998).
Materials and Methods
Participants. All 78 men, 18–26 years old, 
born between March 1977 and January 
1984 to 73 Caucasian women who lived in 
the most dioxin-polluted areas near Seveso, 
Italy, in 1976 (Eskenazi et al. 2004; Mocarelli 
et al. 1991; Needham et al. 1997–1998) were 
invited to participate. Thirty-nine of these 
men, who are the sons of 36 of the 73 women 
(mean age, 24.8 ± 5.6 years at the date of acci-
dent), actually participated; 21 were breast-
fed, and 18 were formula-fed (Table 1). This 
further subdivision allowed us to separate the 
exposed men into two groups: men who had 
been exposed in utero only (those formula-fed 
and not breast-fed), and men who had been 
exposed perinatally—that is, both in utero 
and during nursing (breast-fed) (Table 1).
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Ba c k g r o u n d: In recent decades, young men in some industrialized areas have reportedly   experienced 
a decrease in semen quality.
oB j e c t i v e: We examined effects of perinatal dioxin exposure on sperm quality and reproductive 
hormones.
Me t h o d s : We investigated sperm quality and hormone concentrations in 39 sons (mean age, 
22.5 years) born between 1977 and 1984 to mothers exposed to dioxin after the accident in Seveso, 
Italy (1976), and 58 comparisons (mean age, 24.6 years) born to mothers exposed only to back-
ground dioxin. Maternal dioxin levels at conception were extrapolated from the concentrations 
measured in 1976 serum samples.
re s u l t s: The 21 breast-fed sons whose exposed mothers had a median serum dioxin concentration 
as low as 19 ppt at conception had lower sperm concentration (36.3 vs. 86.3 million/mL; p = 0.002), 
total count (116.9 vs. 231.1; p = 0.02), progressive motility (35.8 vs. 44.2%; p = 0.03), and total 
motile count (38.7 vs. 98 million; p = 0.01) than did the 36 breast-fed comparisons. The 18 formula-
fed exposed and the 22 formula-fed and 36 breast-fed comparisons (maternal dioxin background 
10 ppt at conception) had no sperm-related differences. Follicle-stimulating hormone was higher in 
the breast-fed exposed group than in the breast-fed comparisons (4.1 vs. 2.63 IU/L; p = 0.03) or the 
formula-fed exposed (4.1 vs. 2.6 IU/L; p = 0.04), and inhibin B was lower (breast-fed exposed group, 
70.2; breast-fed comparisons, 101.8 pg/mL, p = 0.01; formula-fed exposed, 99.9 pg/mL, p = 0.02).
co n c l u s i o n s: In utero and lactational exposure of children to relatively low dioxin doses can per-
manently reduce sperm quality.
key w o r d s : breast-feeding, dioxin, environmental endocrine disrupters, human sperm impairment, 
human sperm quality, perinatal exposure, reproductive hormones, TCDD. Environ Health Perspect 
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The exposure status of the mothers of the 
exposed men (either participating or refus-
ing) was verified by measuring dioxin levels 
in their serum, which was collected soon after 
the explosion. There were no significant dif-
ferences in median TCDD serum concentra-
tions in mothers of refusing men compared 
with the mothers of participating ones (36 vs. 
51.7 ppt). Twenty exposed mothers breast-fed 
21 sons, and 17 exposed mothers formula-fed 
18 sons. Of these mothers, three each had 
two sons: One mother had a son in 1977 who 
was formula-fed, and another in 1981 who 
was breast-fed; one mother had a son in 1978 
and another in 1980, both of whom were 
breast-fed; and one mother had a son in 1977 
and another in 1983, both of whom were 
formula-fed. Sons of dioxin-exposed women 
whose spouses were also exposed, as well as 
all men with reported diseases (Table 1), 
were excluded.
As a control, a comparison group of 123 
consecutive healthy volunteer permanent blood 
donors (in Italy, blood donors have medical 
examinations performed every 3 months) of 
the same age and similar socioeconomic sta-
tus as the exposed men, but whose mothers 
had not lived in the TCDD-contaminated 
areas, were invited to participate; they lacked 
additional accidental dioxin exposure (but did 
have the background exposure), and they were 
comparable in terms of breast-feeding and for-
mula feeding. Fifty-eight of these men actually 
participated; 36 were breast-fed, and 22 were 
formula-fed (Table 1).
All participants completed a ques-
tionnaire on health, socioeconomic status, 
smoking and drinking habits, and working 
conditions. Participants also provided infor-
mation on their weight at birth and how long 
they nursed as infants. They were screened 
for hidden diseases by clinical laboratory tests 
(aspartate aminotransferase, alanine amin-
otransferase, γ-glutamyl transferase, total cho-
lesterol, high-density lipoprotein cholesterol, 
low-density lipoprotein cholesterol, C-reactive 
protein, glucose, creatinine, complete blood 
cell count and differential, hemoglobin, hepa-
titis B surface antigen, hepatitis B core anti-
body, hepatitis C, urine analysis) and donated 
blood and semen samples.
The study protocol was approved by insti-
tutional human subjects committee (Istituto 
di Ricovero e Cura a Carattere Scientifico 
Don Gnocchi, Milano, Italy). All study par-
ticipants gave written informed consent.
Laboratory data. Semen samples were col-
lected from participants as a postmasturbatory 
at-home semen sample, which was transported 
to the Desio Hospital laboratory at about 37°C 
and kept at that temperature until examina-
tion, which occurred within 1 hr from ejacula-
tion. Blind tests were performed by the same 
two technicians according to the World Health 
Organization (WHO 1999) recommendations. 
Sperm percentages of A + B grades of motility, 
that is, progressive motility, were assessed at 
400× magnification on a microscope heating 
stage (37°C) in duplicate, and concentration 
was measured using a Bürker-Türk cham-
ber at phase contrast (400×). Morphology 
was evaluated by the same observer on 300 
Papanicolaou-stained sperm per slide (David 
et al. 1975; Jouannet et al. 1988).
For serum hormone analysis, fasting blood 
samples were obtained on the same morning 
as the semen collection. An aliquot of serum 
was stored frozen at –80°C, and hormone lev-
els were measured in large batches in order to 
reduce interassay variability. FSH, inhibin B, 
serum 17-β-estradiol (E2), and luteiniz-
ing hormone (LH) were measured accord-
ing to established immunometric methods. 
Testosterone was measured by radioimmuno-
assay. Quality control protocols were strictly 
applied for all tests using Westgard’s multirule 
(Westgard QC 2009). Intra- and inter  assay 
coefficients of variation were, respectively, 
2.7% and 4.5% for FSH, 4.2% and 6.7% 
for inhibin B, 2.5% and 4.6% for E2, 1.8% 
and 3.4% for LH, and 3.4% and 6.6% for 
testosterone. Sensitivity was 0.1 IU/L for 
FSH, 7.0 pg/mL for inhibin B, 15 pg/mL for 
E2, 0.05 mIU/mL for LH, and 0.02 ng/mL 
for testosterone.
All serum TCDD measurements taken 
from maternal serum samples stored frozen 
since 1976–1977 were conducted by isotope-
dilution high-resolution mass spectrom-
etry at the Centers for Disease Control and 
Prevention (Atlanta, GA, USA) (Patterson 
et al. 1987). The estimated individual mater-
nal serum TCDD concentration at the time of 
conception was calculated for 20–42 years of 
age by using the TCDD serum concentration 
in 1976–1977 and the TCDD half-life for 
Table 1. Characteristics of study participants according to dioxin exposure of the mother and to the type 
of nursing.
Characteristic Exposed group Comparison group
Recruited for the study (n) 78 123
Refused (n) 37 62
Interested (n) 41 61
Compliance (%) 53 50
Excluded from the study (n)a
Varicocele 1 2
Varicocele and cryptorchidism 1 1
Participants (n) 39 58
Age [years (mean ± SD)] 22.5 ± 2.2 24.6 ± 2.0
Age of mothers at conception [years (mean ± SD)] 28.2 ± 5.4 28.1 ± 4.8
Nursing
Breast-fed [n (%)] 21 (54) 36 (62)
Duration of breast-feeding [months (mean)]b 4.06 5.03
Formula-fed [n (%)] 18 (46) 22 (38)
BMI (kg/m2) [n (%)]
< 25 33 (85) 48 (83)
25–30 6 (15) 10 (17)
> 30 — —
Days of abstinencec (mean ± SD)
All 4.2 ± 1.57 4.2 ± 1.77
Breast-fed 3.9 ± 1.58 4.4 ± 1.79
Formula-fed 4.5 ± 1.56 4.0 ± 1.77
aExcluded for self-reported causes (questionnaire) or because of pathologic results of clinical laboratory tests (see 
“Materials and Methods”). bData on duration of breast-feeding were missing for four comparisons. cDays without ejacu-
lation before semen sampling.
Table 2. Serum TCDD concentrations (percentile distribution) of mothers at exposure in 1976 and extrapo-
lated values at conception of their sons.
Percentile (ppt)a
Mothers 5th 25th Median 75th 95th
At exposure (July 1976)
All mothers (n = 36) 17.0 26.6 51.7 115.0 321.0
Mothers who breast-fed (n = 20) 17.0 25.2 46.8 115.0 321.0
Mothers who formula-fed (n = 17) 19.0 29.1 55.7 87.6 301.0
At conception (1976–1983)
All mothers 11.8 16.2 26.0 58.9 232.3
Mothers who breast-fedb 11.8 13.1 19.0 58.9 117.1
Mothers who formula-fedc 17.0 20.6 27.9 54.6 240.3
Mothers of comparisons were considered as exposed to average background TCDD level of 10 ppt in 1976 (Eskenazi 
et al. 2004). 
aValues are parts per trillion TCDD concentration expressed on serum lipid basis. bAfter breast-feeding for 4–5 months, 
the TCDD value in the child roughly doubles compared with the conception value (Abraham et al. 1998). cThe formula-fed 
men were exposed to dioxin only in utero.Perinatal dioxin exposure can impair semen quality
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women of that age, estimated to be an aver-
age of 4 years (range, 2.1–6.7 years) (Kreuzer 
et al. 1997). For the equation and an exam-
ple of calculation, see Supplemental Material 
(doi:10.1289/ehp.1002134). Serum samples 
collected in 2002–2003, both from the case 
men and from their comparisons, were also 
analyzed for dioxin.
Statistical analysis. A general database was 
established and maintained using SAS soft-
ware (version 8.2; SAS Institute Inc., Cary, 
NC, USA). Sperm and hormone data were fit-
ted with a general linear model that included 
group, lactation class, and group × lactation 
class interaction as terms. Covariates included 
age at time of tests, length of abstinence in 
days, smoking habits (the total number of 
cigarettes smoked per day during months of 
habitual smoking), chemical exposures (mostly 
organic solvents, adhesives, paints, colors, 
and powders), body mass index (BMI) at 
the moment of the study, alcohol use (grams 
per day), educational level, and employment 
status. Scale transformations were applied to 
approximate normal distribution and homo-
scedasticity. Sperm concentration, total sperm 
count, progressive motile sperm count, and E2, 
testosterone, and FSH concentrations were log 
transformed, whereas semen volume and LH 
and inhibin B concentrations were square root 
transformed. Results were expressed as back 
transformation of least squares means (i.e., the 
means adjusted for all the terms in the model). 
Two types of comparisons were made: among 
groups within lactation class, and among lacta-
tion classes within group.
Results
Dioxin exposure. In 1976, the median serum 
TCDD concentrations in women whose 
eligible sons did and did not participate in 
the study were similar (51.7 vs. 36 ppt). We 
assumed the serum TCDD concentrations 
in the comparison group mothers at concep-
tion (Table 2) were 10 ppt in 1976–1977 
(Eskenazi et al. 2004). All mothers at the time 
were also exposed to a background of dioxin-
like chemicals [polychlorinated dibenzofurans 
(PCDFs) and some polychlorinated biphenyls 
(PCBs)], constituting a total of about 90 ppt 
of dioxin toxic equivalent (TEQ) concentra-
tion, which is added to the concentration of 
TCDD (Eskenazi et al. 2004).
Median maternal TCDD concentrations 
(Table 2) measured in serum collected in 1976 
and extrapolated to conception levels for moth-
ers who breast-fed or formula-fed their chil-
dren were 19.0 and 27.9 ppt, respectively, and 
were not statistically different. Serum TCDD 
concentrations in sons after 4–5 months of 
breast-feeding are considered 2-fold those of 
the mothers (Abraham et al. 1998).
Serum TCDD concentrations measured at 
the time of this study in the exposed breast- and 
formula-fed groups (average, 2.4 ppt and 
1.1 ppt, respectively) and their respective com-
parison groups (average, 1.8 ppt and 1.0 ppt, 
respectively) were not statistically different.
Semen quality. About 50% of both the 
exposed and comparison group men recruited 
for this study complied with semen exami-
nation (Table 1). Figure 1 and Table 3 list 
variables for exposed men and their compari-
sons. The 39 men exposed in utero and dur-
ing nursing had significantly decreased sperm 
concentration (p = 0.01), total sperm count 
(p = 0.03), and number of total motile sperm 
(p = 0.05) relative to the 58 men in the com-
parison group (Table 3, Figure 1A).
A stronger significant effect appeared 
(Table 3) when comparing the 21 breast-fed 
exposed sons and the 36 breast-fed compari-
sons (sperm concentration, p = 0.002; total 
sperm count, p = 0.02; total motile sperm 
count, p = 0.01; progressive motility, p = 0.03; 
see Figure 1A). In contrast, we observed no 
statistical differences between the 18 formu-
la-fed exposed men and the 22 formula-fed 
comparisons or between the 36 breast-fed and 
22 formula-fed comparisons (Table 3). On the 
Figure 1. Differences in sperm variables, FSH, and inhibin B between in utero and breast- or formula-fed 
men exposed to dioxin and comparisons. (A) Lower sperm concentration and the lower total motility of all 
TCDD-exposed men (median maternal TCDD at conception, 26 ppt) with respect to comparisons was related 
mainly to breast-feeding (see also Table 3). (B) The nine breast-fed exposed men belonging to the two high-
est quartiles (median maternal TCDD at conception, 58.9 ppt) had both lower median sperm concentration 
(23.8 × 106/mL) and lower motility (p = 0.0003, p = 0.003, respectively) than did the 36 breast-fed comparisons 
(82.5 × 106/mL). Also, the 12 exposed breast-fed men belonging to the two lowest quartiles (median mater-
nal TCDD at conception, 13.1 ppt) had lower (p = 0.05) sperm concentration (47.3 × 106/mL) than did the 36 
breast-fed comparisons (82.5 × 106/mL). (C) Sperm variables did not statistically differ among all the formula-
fed men exposed to more or less than 26 ppt of TCDD and the formula-fed comparisons. (D) The effect 
of dioxin through breast-feeding on FSH (increasing) and inhibin B (decreasing) values, compared with 
exposed formula-fed and comparison men, was significant and permanent. (E) The low sperm concentra-
tion of TCDD in exposed breast-fed men was strongly correlated to low inhibin B concentration (a marker of 
Sertoli cells). The formula-fed exposed men and comparisons had normal inhibin B concentration.
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other hand, we observed an almost significant 
(p = 0.07) sperm concentration decrease in the 
21 breast-fed exposed men compared with the 
18 formula-fed exposed men. Figure 1A sum-
marizes these observations, with TCDD values. 
In examining any differences in out-
come, we found that the nine breast-fed 
men belonging to the two highest quartiles 
of TCDD serum concentrations (median 
TCDD, 58.9 ppt) did show lower sperm 
concentration (p = 0.0003) and total motil-
ity (p = 0.003) than the 36 breast-fed com-
parisons (Figure 1B); in the equivalent 
formula-fed groups, we observed no statisti-
cal differences between the 10 exposed men 
(median TCDD, 54.6 ppt) and the 22 com-
parisons (Figure 1C). We observed similar 
effects for total sperm motility (Figure 1B,C). 
For the men in the two lowest quartiles, who 
had serum TCDD concentrations < 26 ppt 
(median TCDD, 13.1 ppt), the only dif-
ference was a lower sperm concentration 
(p = 0.05) in the 12 exposed breast-fed men 
with respect to the 36 comparison breast-fed 
men (Figure 1B).
These data also showed that a much 
lower semen concentration was present in 
the breast-fed men with the highest exposure, 
but the dose–response model did not reach 
statistical significance; we observed only a ten-
dency, possibly because of the small number 
of cases. We did not observe this result with 
the formula-fed exposed men.
We observed no statistically significant 
difference for sperm morphology parameters 
between exposed and comparison groups.
Hormones. The 21 breast-fed exposed 
men had higher FSH concentrations than 
did both the 36 breast-fed comparison men 
(p = 0.03) and the 18 formula-fed exposed 
men (p = 0.04; Table 3), whereas inhibin B 
was significantly decreased (p = 0.01 and 
p = 0.02, respectively). Figure 1D,E, illus-
trates the relationships between inhibin B and 
FSH, and inhibin B and sperm concentration 
in the different conditions.
We observed no statistically significant dif-
ferences for E2, testosterone, and LH between 
exposed and comparison groups.
Discussion
The results of this study clearly indicate that 
continuous exposure of males starting from low 
concentrations of dioxin before and after birth 
due to the mother being exposed during the 
Seveso accident, and then due to breast-feeding 
during “neonatal minipuberty,” results in a per-
manent impairment of the reproductive system 
(reduction of about 50% of sperm concentra-
tion and total sperm count and about 20% of 
sperm progressive motility, and increase of FSH 
with decrease of inhibin B) in young adulthood.
This impairment is not seen in males who 
were born to similarly exposed Seveso mothers 
who did not breast-feed. In fact, this group of 
men had sperm counts similar to those of the 
breast-fed and formula-fed comparison group.
The breast-fed exposed men had lower 
sperm variables than did the breast-fed 
Table 3. Differences in sperm and hormone data between men exposed to dioxin in utero (i.e., formula-fed) or also through breast-feeding and same-age comparisons.
Breast-fed Formula-fed
p-Value,a breast-fed 
versus formula-fed
Characteristic
Exposed group 
(n = 39)
Comparison group 
(n = 58)
Exposed group 
(n = 21)
Comparison group 
(n = 36)
Exposed group 
(n = 18)
Comparison group 
(n = 22)
Exposed 
group
Comparison 
group
Semen volume (mL)
Median (25th–75th 
percentile)
3.0 (2.2–3.8) 3.3 (2.4–4.3) 3.0 (2.3–3.8) 3.4 (2.1–4.2) 3.0 (2.0–3.8) 3.0 (2.4–4.4)
Adjusted meanb (–/+ SE)c 3.2 (3.0/3.4) 3.0 (2.8/3.2) 3.4 (3.1/3.7) 2.9 (2.6/3.1) 3.0 (2.7/3.3) 3.2 (2.9/3.5)
p-Valuea 0.60 0.21 0.68 0.39 0.38
Sperm concentration (106/mL)
Median (25th–75th 
percentile)
61.5 (32.1–100.0) 88.7 (54.6–133.1) 54.4 (22.1–68.5) 99.6 (58.2–141.6) 81.1 (37.2–107.3) 81.8 (41.4–96.1)
Adjusted meanb (–/+ SE)c 46.2 (39.8/53.6) 81.0 (71.9/91.1) 36.3 (29.8/44.2) 86.3 (74.1/100.6) 60.8 (49.4/74.9) 73.2 (60.5/88.6)
p-Value 0.01 0.002 0.53 0.07 0.51
Sperm total count (106)
Median (25th–75th 
percentile)
143.9 (78.1–336.2) 230.6 (162.6–422.3) 108.2 (57.0–209.0) 270.8 (178.1–431.8) 222.0 (118.3–349.2) 214.1 (134.4–359.7)
Adjusted meanb (–/+ SE)c 139.2 (119.3/162.4) 229.9 (203.4/259.9) 116.9 (95.1/143.6) 231.1 (197.0/271.2) 171.4 (137.9/213.1) 227.0 (185.9/277.1)
p-Value 0.03 0.02 0.36 0.19 0.94
Sperm progressive motility (%)d
Median (25th–75th 
percentile)
39.0 (33.0–47.0) 41.5 (34.0–50.0) 37.0 (31.0–44.0) 43.5 (38.5–51.5) 40.0 (37.0–48.0) 36.5 (32.0–49.0)
Adjusted meanb (–/+ SE)c 38.7 (36.3/40.9) 41.5 (39.8/43.2) 35.8 (33.0/38.5) 44.2 (42.0/46.3) 41.7 (38.8/44.6) 37.4 (34.8/40.1)
p-Value 0.47 0.03 0.30 0.13 0.06
Progressive motile sperm count (106)e
Median (25th–75th 
percentile)
58.5 (24.8–141.2) 98.1 (65.9–193.9) 44.4 (21.1–81.2) 111.7 (75.0–197.1) 87.2 (42.6–143.2) 94.9 (41.7–150.2)
Adjusted meanb (–/+ SE)c 50.6 (41.4/61.8) 90.5 (77.1/106.2) 38.7 (29.6/50.6) 98.0 (79.7/120.6) 68.5 (51.6/90.8) 80.0 (61.7/103.6)
p-Value 0.05 0.01 0.70 0.13 0.55
FSH (IU/L)
Median (25th–75th 
percentile)
3.2 (2.1–5.3) 2.7 (1.9–4.7) 3.7 (2.9–6.4) 2.6 (1.8–4.7) 2.7 (1.6–3.8) 3.2 (2.3–4.7)
Adjusted meanb (–/+ SE)c 3.3 (3.0/3.7) 2.7 (2.4/2.9) 4.1 (3.5/4.8) 2.6 (2.3/3.0) 2.6 (2.2/3.1) 2.8 (2.4/3.2)
p-Value 0.23 0.03 0.79 0.04 0.79
Inhibin B (pg/mL)
Median (25th–75th 
percentile)
77.6 (49.3–114.7) 99.6 (86.4–129.7) 73.2 (49.3–89.9) 105.7 (87.6–126.7) 87.0 (50.2–133.2) 96.0 (83.4–133.2)
Adjusted meanb (–/+ SE)c 83.2 (76.4/90.3) 100.0 (94.0/106.2) 70.2 (62.0/78.9) 101.8 (94.0/109.8) 99.9 (89.5/110.8) 97.2 (87.8/107.0)
p-Value 0.13 0.01 0.85 0.02 0.72
ap-Values refer to differences adjusted by abstinence time (days), BMI, smoking status and total number of cigarettes per day during months of habitual smoking, age at the time of 
test, chemical substances exposure, alcohol use (g/day), and education level for sperm data. Hormone data were not adjusted for education level, employment status, and abstinence 
time. bValues derived from back-transformation of log (sperm concentration, sperm total count, progressive motile sperm count, and FSH) and square-root transformation (semen vol-
ume and inhibin B). cValues indicate adjusted mean minus the SE/adjusted mean plus the SE. dConsidered as A + B grades of progressive motility of sperm, according to WHO (1999). 
eConsidered as A + B grades of progressive motility of sperm per total sperm count, according to WHO (1999).Perinatal dioxin exposure can impair semen quality
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comparison and formula-fed exposed men. 
In the latter case, statistical significance was 
not reached, probably because of the small 
number of cases. These observations on 
semen quality are considerably reinforced by 
corresponding changes in hormone levels: 
decreased inhibin B and increased FSH found 
in the breast-fed exposed group.
We had the rather unique opportunity to 
discriminate TCDD exposure with respect 
to background levels. Men exposed to rather 
high maternal serum TCDD concentrations 
at birth, such as 54.6 ppt (the 75th percentile 
of formula-fed exposed children), plus the 
then background value of 90 ppt of dioxin-
like chemicals, did not show differences 
compared with the breast- and formula-fed 
comparison group members.
At the age of 4–5 months, formula-fed 
infants almost double their birth weight and 
halve the dioxin concentration, to about 
27 ppt for the formula-fed exposed group 
and 5 ppt for the formula-fed comparison 
group, whereas the breast-fed comparison 
group approximately doubles the concentra-
tion to 20 ppt because of background dioxin 
exposure. On the other hand, the median of 
19 ppt of dioxin in the breast-fed exposed 
group increases with breast-feeding to about 
40 ppt. Our data show that impaired semen 
quality in adulthood results from exposure 
in utero, as well as continuous exposure 
through breast-feeding during “neonatal 
minipuberty,” with adverse effects starting 
with a dioxin exposure range of 19–40 ppt 
and higher (the concentrations of background 
dioxin-like chemicals must also be added). 
Similar doses of TCDD administered to rhe-
sus monkeys during pregnancy and lactation 
have recently been shown to produce lower 
semen quality in their young adult offspring 
(Arima et al. 2009). It would be interesting 
to investigate the effect of TCDD administra-
tion only during lactation.
Our observations show for the first time 
that continuous exposure of the develop-
ing human male in utero, and even more so 
during lactation, the “neonatal minipuberty 
period,” to modest elevations of dioxin above 
background exposure levels can permanently 
impair later adult sperm production.
In fact, the only similar data (Guo et al. 
2000) are related to in utero and nursing expo-
sure of children to high doses of burned PCBs/
PCDFs, but not to TCDD. That study dem-
onstrated a reduction in sperm motility, but 
not density, as well as reduced egg penetration 
ability. Unfortunately, data concerning the spe-
cific concentration of the toxicants in maternal 
blood at conception were not available.
Mechanism of action. Dioxin and the 
structurally related PCDF chemicals mediate 
their toxic effect (but with different poten-
cies) mainly as a ligand to the same aryl 
hydrocarbon receptor (AHR)/AHR nuclear 
translocator (ARNT) complex that binds to 
the xenobiotic responsive element (XRE; also 
called dioxin-responsive element, DRE) on tar-
get DNA. The widely expressed AHR/ARNT, 
when ligand activated, interacts with several 
transcription factors, steroids, and growth fac-
tors and possibly plays a critical constitutive 
role, especially in early tissue development. 
Through targeted gene networks, AHR/ARNT 
regulates or directly intervenes in reproductive 
system development (Schultz et al. 2003).
As our study shows, the untimely inter-
ference of dioxin in utero and within the 
first 4–5 months of life (the “neonatal mini-
puberty”) (Forest et al. 1973; Quigley 2002) 
results in a permanent impairing effect. It is 
during this time that the human testes almost 
double their volume (Cortes et al. 1987), 
due in great part to Sertoli cell proliferation, 
which determines spermatogenic potential 
(Sharpe et al. 2003). An indication of possible 
Sertoli cell number (or functionality) reduc-
tion is given by the decrease of inhibin B, a 
marker of their activity, associated with the 
decrease of sperm concentration, not only 
in the exposed breast-fed with respect to the 
comparison breast-fed group, but also in the 
exposed breast-fed compared with the exposed 
formula-fed group. The increase of FSH 
associated with the decrease of inhibin B (as 
observed here) has been reported to be a very 
sensitive marker for impaired spermatogenesis 
in men (von Eckardstein et al. 1999).
It is well established that sons born to 
mothers who smoked heavily in pregnancy have 
a 20–50% reduction in sperm concentration in 
adulthood (Jensen et al. 2005; Jensen et al. 
2004; Ramlau-Hansen et al. 2007), reduced 
blood levels of inhibin B, and increased FSH 
(Storgaard et al. 2003), compared with unex-
posed males. No information is provided about 
smoking during breast-feeding in these studies, 
but it is likely that exposure to the chemicals in 
tobacco smoke occurred both prenatally and 
postnatally, similar to our dioxin study. This is 
relevant to our data because a common mecha-
nism of the phenomenon we observed and 
the one due to smoking could be the action 
on XRE (Kasai et al. 2006) of some polycyclic 
aromatic hydrocarbon (PAH) compounds con-
tained in cigarette smoke, using the same AHR 
as dioxin.
It has also been shown that PAHs have a 
negative impact on rat and human Sertoli cell 
function (Coutts et al. 2007; Raychoudhury 
and Kubinski 2003).
Relevance to general population and indi-
viduals. These observed effects of perinatal 
dioxin exposure on lowering adult sperm 
counts might also explain, in part, the wider 
semen quality reduction reported in young 
men in some industrialized regions, such as 
in Spain, Denmark, and Germany (Andersen 
et al. 2000; López-Teijòn et al. 2008; Paasch 
et al. 2008; Zheng et al. 1997). The men 
observed in these studies were in fact born in 
the 1970s and 1980s to mothers born in the 
1950s and 1960s, a period when environmen-
tal concentrations of dioxin and dioxin-like 
chemicals peaked (Hagenmaier and Walczok 
1996). The bioaccumulation of these com-
pounds with age is well demonstrated, and a 
concurrent effect of maternal smoking could 
also contribute to this phenomenon.
Because of environmental policies insti-
tuted throughout most of Europe and the 
United States, TCDD and total TEQ con-
centrations in women 20–40 years of age 
have recently decreased sharply, to less than 
2 ppt and 12 ppt, respectively (Päpke 1998; 
Patterson et al. 2008). Thus, current serum 
dioxin levels in infants in these areas, even 
after being increased 2- to 3-fold because of 
breast-feeding, are far from the concentrations 
that would yield adverse effects.
Conclusions
Our data indicate for the first time that envi-
ronmental chemical exposure to dioxin con-
tinuously throughout the perinatal period 
permanently reduces semen quality and sperm 
counts in young men and demonstrates that 
the male reproductive system is dramati-
cally sensitive to the action of dioxin, start-
ing from rather low doses (~ 19 ppt) in utero 
and doubled by breast-feeding during “neo-
natal minipuberty,” resulting in permanent 
impairment in the adult (reduction of ~ 50% 
of sperm concentration and total sperm count 
and ~ 20% of sperm progressive motility, with 
increased FSH and decreased inhibin B).
Although our findings are derived from 
examining a unique cohort of men exposed 
perinatally to supranormal dioxin levels, they 
may have relevance to the wider population 
of young men in industrialized countries and 
may partly explain the reported widespread 
occurrence of low sperm counts in young 
men in Europe. Our findings also raise con-
cern for those areas of the world in which 
rapid industrial development may cause wide-
spread distribution of environmental endo-
crine-disrupting chemicals, such as dioxin and 
  dioxin-like chemicals.
Furthermore, our data should encourage 
studies of semen quality in men of appropri-
ate ages, comparing breast-fed and formula-
fed groups, especially if this could be linked 
to proximity to polluted areas at the time of 
perinatal life.
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